Literature DB >> 20698836

Differential regulation of NMDA receptor function by DJ-1 and PINK1.

Ning Chang1, Lijun Li, Rong Hu, Yuexin Shan, Baosong Liu, Lei Li, Hanbin Wang, Hua Feng, Dianshi Wang, Carol Cheung, Mingxia Liao, Qi Wan.   

Abstract

Dysfunction of PTEN-induced kinase 1 (PINK1) or DJ-1 promotes neuronal death and is implicated in the pathogenesis of Parkinson's disease, but the underlying mechanisms remain unclear. Given the roles of N-methyl-d-aspartate receptor (NMDAr)-mediated neurotoxicity in various brain disorders including cerebral ischemia and neurodegenerative diseases, we investigated the effects of PINK1 and DJ-1 on NMDAr function. Using protein overexpression and knockdown approaches, we showed that PINK1 increased NMDAr-mediated whole-cell currents by enhancing the function of NR2A-containing NMDAr subtype (NR2ACNR). However, DJ-1 decreased NMDAr-mediated currents, which was mediated through the inhibition of both NR2ACNR and NR2B-containing NMDAr subtype (NR2BCNR). We revealed that the knockdown of DJ-1 enhanced PTEN expression, which not only potentiated NR2BCNR function but also increased PINK1 expression that led to NR2ACNR potentiation. These results indicate that NMDAr function is differentially regulated by DJ-1-dependent signal pathways DJ-1/PTEN/NR2BCNR and DJ-1/PTEN/PINK1/NR2ACNR. Our results further showed that the suppression of DJ-1, while promoted NMDA-induced neuronal death through the overactivation of PTEN/NR2BCNR-dependent cell death pathway, induced a neuroprotective effect to counteract DJ-1 dysfunction-mediated neuronal death signaling through activating PTEN/PINK1/NR2ACNR cell survival-promoting pathway. Thus, PINK1 acts with DJ-1 in a common pathway to regulate NMDAr-mediated neuronal death. This study suggests that the DJ-1/PTEN/NR2BCNR and DJ-1/PTEN/PINK1/NR2ACNR pathways may represent potential therapeutic targets for the development of neuroprotection strategy in the treatment of brain injuries and neurodegenerative diseases such as Parkinson's disease.
© 2010 The Authors Aging Cell © 2010 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20698836     DOI: 10.1111/j.1474-9726.2010.00615.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  10 in total

1.  PINK1 Silencing Modifies Dendritic Spine Dynamics of Mouse Hippocampal Neurons.

Authors:  C J Hernández; C Báez-Becerra; M J Contreras-Zárate; H Arboleda; G Arboleda
Journal:  J Mol Neurosci       Date:  2019-09-05       Impact factor: 3.444

2.  Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A.

Authors:  Ruben K Dagda; Irene Pien; Ruth Wang; Jianhui Zhu; Kent Z Q Wang; Jason Callio; Tania Das Banerjee; Raul Y Dagda; Charleen T Chu
Journal:  J Neurochem       Date:  2013-11-13       Impact factor: 5.372

3.  N-Methyl-D-Aspartate Receptor Signaling-Protein Kinases Crosstalk in Cerebral Ischemia.

Authors:  Atilla Engin; Ayse Basak Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Differential roles of GluN2A- and GluN2B-containing NMDA receptors in neuronal survival and death.

Authors:  Brendan Lujan; Xiaoxuan Liu; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

5.  Glycine confers neuroprotection through microRNA-301a/PTEN signaling.

Authors:  Juan Chen; Yang Zhuang; Zhi-Feng Zhang; Shu Wang; Ping Jin; Chunjiang He; Peng-Chao Hu; Ze-Fen Wang; Zhi-Qiang Li; Guang-Ming Xia; Gang Li; Yuan Wang; Qi Wan
Journal:  Mol Brain       Date:  2016-05-26       Impact factor: 4.041

6.  A synthetic BBB-permeable tripeptide GCF confers neuroprotection by increasing glycine in the ischemic brain.

Authors:  Juan Chen; Yang Zhuang; Ya Zhang; Huabao Liao; Rui Liu; Jing Cheng; Zhifeng Zhang; Jiangdong Sun; Jingchen Gao; Xiyuran Wang; Shujun Chen; Liang Zhang; Fengyuan Che; Qi Wan
Journal:  Front Pharmacol       Date:  2022-08-15       Impact factor: 5.988

Review 7.  NMDA Receptor C-Terminal Domain Signalling in Development, Maturity, and Disease.

Authors:  Kirsty Haddow; Peter C Kind; Giles E Hardingham
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

8.  Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment.

Authors:  Mei Zheng; Yujie Shi; Dongsheng Fan
Journal:  Neural Regen Res       Date:  2013-12-15       Impact factor: 5.135

Review 9.  Synaptojanin 1 mutation in Parkinson's disease brings further insight into the neuropathological mechanisms.

Authors:  Valérie Drouet; Suzanne Lesage
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

10.  Glycine triggers a non-ionotropic activity of GluN2A-containing NMDA receptors to confer neuroprotection.

Authors:  Rong Hu; Juan Chen; Brendan Lujan; Ruixue Lei; Mi Zhang; Zefen Wang; Mingxia Liao; Zhiqiang Li; Yu Wan; Fang Liu; Hua Feng; Qi Wan
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.